Adherence to oral antiretroviral therapy in Canada, 2010–2020

Objective: To assess antiretroviral therapy (ART) adherence among people with HIV (PWH) in Canada and identify baseline characteristics associated with suboptimal adherence (<95%). Design: Retrospective observational study using data from the National Prescription Drug Utilization Information Sys...

Full description

Bibliographic Details
Published in:AIDS
Main Authors: Angel, Jonathan B., Freilich, Jonatan, Arthurs, Erin, Ban, Joann K., Lachaine, Jean, Chounta, Vasiliki, Harris, Marianne
Format: Article in Journal/Newspaper
Language:English
Published: Ovid Technologies (Wolters Kluwer Health) 2023
Subjects:
Online Access:http://dx.doi.org/10.1097/qad.0000000000003648
https://journals.lww.com/10.1097/QAD.0000000000003648
id crovidcr:10.1097/qad.0000000000003648
record_format openpolar
spelling crovidcr:10.1097/qad.0000000000003648 2024-05-19T07:44:19+00:00 Adherence to oral antiretroviral therapy in Canada, 2010–2020 Angel, Jonathan B. Freilich, Jonatan Arthurs, Erin Ban, Joann K. Lachaine, Jean Chounta, Vasiliki Harris, Marianne 2023 http://dx.doi.org/10.1097/qad.0000000000003648 https://journals.lww.com/10.1097/QAD.0000000000003648 en eng Ovid Technologies (Wolters Kluwer Health) http://creativecommons.org/licenses/by-nc-nd/4.0 AIDS volume 37, issue 13, page 2031-2040 ISSN 0269-9370 1473-5571 Infectious Diseases Immunology Immunology and Allergy journal-article 2023 crovidcr https://doi.org/10.1097/qad.0000000000003648 2024-04-22T07:18:39Z Objective: To assess antiretroviral therapy (ART) adherence among people with HIV (PWH) in Canada and identify baseline characteristics associated with suboptimal adherence (<95%). Design: Retrospective observational study using data from the National Prescription Drug Utilization Information System and Régie de l’assurance maladie Quebec (RAMQ) Public Prescription Drug Insurance Plan. Methods: This analysis included PWH aged 18 years or older who initiated an ART regimen and were followed for at least 12 months (2010–2020). Patient characteristics were summarized using medical/pharmacy claims data from seven provinces (Alberta, Manitoba, New Brunswick, Newfoundland and Labrador, Ontario, Saskatchewan, and Quebec). ART regimen at index date (first dispensing of a regimen including a core agent) was defined as a single-tablet or multitablet regimen (MTR). Adherence was calculated using a Proportion of Days Covered approach, based on ART dispensing, recorded between April 2010 and the last available date. Multivariate linear regression analysis was used to determine correlations between suboptimal adherence and baseline characteristics. Results: We identified 19 322 eligible PWH, 44.7% of whom had suboptimal adherence (<95%). Among 12 594 PWH with evaluable baseline data, 10 673 (84.8%) were ART-naive, 74.2% were men, mean age was 42.9 years, and 54.1% received a MTR as their ART. Based on multivariate regression analysis, suboptimal adherence was significantly associated with multitablet ART ( P < 0.001) and younger age ( P < 0.001) but not sex. Conclusion: Almost half of adult PWH in Canada had suboptimal adherence to ART. Better understanding of factors influencing adherence may help address gaps in current care practices that may impact adherence. Article in Journal/Newspaper Newfoundland Ovid AIDS
institution Open Polar
collection Ovid
op_collection_id crovidcr
language English
topic Infectious Diseases
Immunology
Immunology and Allergy
spellingShingle Infectious Diseases
Immunology
Immunology and Allergy
Angel, Jonathan B.
Freilich, Jonatan
Arthurs, Erin
Ban, Joann K.
Lachaine, Jean
Chounta, Vasiliki
Harris, Marianne
Adherence to oral antiretroviral therapy in Canada, 2010–2020
topic_facet Infectious Diseases
Immunology
Immunology and Allergy
description Objective: To assess antiretroviral therapy (ART) adherence among people with HIV (PWH) in Canada and identify baseline characteristics associated with suboptimal adherence (<95%). Design: Retrospective observational study using data from the National Prescription Drug Utilization Information System and Régie de l’assurance maladie Quebec (RAMQ) Public Prescription Drug Insurance Plan. Methods: This analysis included PWH aged 18 years or older who initiated an ART regimen and were followed for at least 12 months (2010–2020). Patient characteristics were summarized using medical/pharmacy claims data from seven provinces (Alberta, Manitoba, New Brunswick, Newfoundland and Labrador, Ontario, Saskatchewan, and Quebec). ART regimen at index date (first dispensing of a regimen including a core agent) was defined as a single-tablet or multitablet regimen (MTR). Adherence was calculated using a Proportion of Days Covered approach, based on ART dispensing, recorded between April 2010 and the last available date. Multivariate linear regression analysis was used to determine correlations between suboptimal adherence and baseline characteristics. Results: We identified 19 322 eligible PWH, 44.7% of whom had suboptimal adherence (<95%). Among 12 594 PWH with evaluable baseline data, 10 673 (84.8%) were ART-naive, 74.2% were men, mean age was 42.9 years, and 54.1% received a MTR as their ART. Based on multivariate regression analysis, suboptimal adherence was significantly associated with multitablet ART ( P < 0.001) and younger age ( P < 0.001) but not sex. Conclusion: Almost half of adult PWH in Canada had suboptimal adherence to ART. Better understanding of factors influencing adherence may help address gaps in current care practices that may impact adherence.
format Article in Journal/Newspaper
author Angel, Jonathan B.
Freilich, Jonatan
Arthurs, Erin
Ban, Joann K.
Lachaine, Jean
Chounta, Vasiliki
Harris, Marianne
author_facet Angel, Jonathan B.
Freilich, Jonatan
Arthurs, Erin
Ban, Joann K.
Lachaine, Jean
Chounta, Vasiliki
Harris, Marianne
author_sort Angel, Jonathan B.
title Adherence to oral antiretroviral therapy in Canada, 2010–2020
title_short Adherence to oral antiretroviral therapy in Canada, 2010–2020
title_full Adherence to oral antiretroviral therapy in Canada, 2010–2020
title_fullStr Adherence to oral antiretroviral therapy in Canada, 2010–2020
title_full_unstemmed Adherence to oral antiretroviral therapy in Canada, 2010–2020
title_sort adherence to oral antiretroviral therapy in canada, 2010–2020
publisher Ovid Technologies (Wolters Kluwer Health)
publishDate 2023
url http://dx.doi.org/10.1097/qad.0000000000003648
https://journals.lww.com/10.1097/QAD.0000000000003648
genre Newfoundland
genre_facet Newfoundland
op_source AIDS
volume 37, issue 13, page 2031-2040
ISSN 0269-9370 1473-5571
op_rights http://creativecommons.org/licenses/by-nc-nd/4.0
op_doi https://doi.org/10.1097/qad.0000000000003648
container_title AIDS
_version_ 1799484086330327040